Daniel Blaney is an Executive Director of Global Strategic Marketing, specializing as the Oncology Pipeline Lead at Gilead Sciences since 2021. Previously, Daniel held various roles in competitive intelligence and analytics, including a Director position at Gilead and consulting at Deallus Consulting. Daniel earned an MBA from HEC School of Management in 2012, following a BA in Computer Science from Tufts University in 2005. Their career spans significant contributions to oncology marketing and competitive strategies within the pharmaceutical industry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices